These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


624 related items for PubMed ID: 21834936

  • 1. Response to a selective COX-2 inhibitor in patients with urticaria/angioedema induced by nonsteroidal anti-inflammatory drugs.
    Doña I, Blanca-López N, Jagemann LR, Torres MJ, Rondón C, Campo P, Gómez AI, Fernández J, Laguna JJ, Rosado A, Blanca M, Canto G.
    Allergy; 2011 Nov; 66(11):1428-33. PubMed ID: 21834936
    [Abstract] [Full Text] [Related]

  • 2. Tolerance to COX-2 inhibitors in children with hypersensitivity to nonsteroidal anti-inflammatory drugs.
    Corzo JL, Zambonino MA, Muñoz C, Mayorga C, Requena G, Urda A, Gallego C, Blanca M, Torres MJ.
    Br J Dermatol; 2014 Mar; 170(3):725-9. PubMed ID: 24116718
    [Abstract] [Full Text] [Related]

  • 3. Early presentation with angioedema and urticaria in cross-reactive hypersensitivity to nonsteroidal antiinflammatory drugs among young, Asian, atopic children.
    Kidon MI, Kang LW, Chin CW, Hoon LS, See Y, Goh A, Lin JT, Chay OM.
    Pediatrics; 2005 Nov; 116(5):e675-80. PubMed ID: 16230465
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Safety of meloxicam in patients with aspirin/non-steroidal anti-inflammatory drug-induced urticaria and angioedema.
    Göksel O, Aydin O, Misirligil Z, Demirel YS, Bavbek S.
    J Dermatol; 2010 Nov; 37(11):973-9. PubMed ID: 21039786
    [Abstract] [Full Text] [Related]

  • 7. Risk factors for acetaminophen and nimesulide intolerance in patients with NSAID-induced skin disorders.
    Asero R.
    Ann Allergy Asthma Immunol; 1999 Jun; 82(6):554-8. PubMed ID: 10400483
    [Abstract] [Full Text] [Related]

  • 8. Value of the clinical history in the diagnosis of urticaria/angioedema induced by NSAIDs with cross-intolerance.
    Blanca-Lopez N, J Torres M, Doña I, Campo P, Rondón C, Seoane Reula ME, Salas M, Canto G, Blanca M.
    Clin Exp Allergy; 2013 Jan; 43(1):85-91. PubMed ID: 23278883
    [Abstract] [Full Text] [Related]

  • 9. Are drug provocation tests still necessary to test the safety of COX-2 inhibitors in patients with cross-reactive NSAID hypersensitivity?
    Çelik GE, Erkekol FÖ, Aydın Ö, Demirel YS, Mısırlıgil Z.
    Allergol Immunopathol (Madr); 2013 Jan; 41(3):181-8. PubMed ID: 23031659
    [Abstract] [Full Text] [Related]

  • 10. Provocation tests with the offending nonsteroidal anti-inflammatory drugs in patients with urticaria/angioedema reactions.
    Zisa G, Riccobono F, Bommarito L, D'Antonio C, Calamari AM, Poppa M, Moschella MA, Di Pietrantonj C, Galimberti M.
    Allergy Asthma Proc; 2012 Jan; 33(5):421-6. PubMed ID: 23026184
    [Abstract] [Full Text] [Related]

  • 11. Natural evolution in patients with nonsteroidal anti-inflammatory drug-induced urticaria/angioedema.
    Doña I, Barrionuevo E, Salas M, Cornejo-García JA, Perkins JR, Bogas G, Prieto A, Torres MJ.
    Allergy; 2017 Sep; 72(9):1346-1355. PubMed ID: 28226401
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The use of nimesulide in patients with acetylsalicylic acid and nonsteroidal anti-inflammatory drug intolerance.
    Bavbek S, Celik G, Ediger D, Mungan D, Demirel YS, Misirligil Z.
    J Asthma; 1999 Dec; 36(8):657-63. PubMed ID: 10609620
    [Abstract] [Full Text] [Related]

  • 15. Tolerance of nonsteroidal anti-inflammatory drug-sensitive patients to the highly specific cyclooxygenase 2 inhibitors rofecoxib and valdecoxib.
    Sánchez-Borges M, Caballero-Fonseca F, Capriles-Hulett A.
    Ann Allergy Asthma Immunol; 2005 Jan; 94(1):34-8. PubMed ID: 15702813
    [Abstract] [Full Text] [Related]

  • 16. Safety of etoricoxib, a specific cyclooxygenase-2 inhibitor, in asthmatic patients with aspirin-exacerbated respiratory disease.
    El Miedany Y, Youssef S, Ahmed I, El Gaafary M.
    Ann Allergy Asthma Immunol; 2006 Jul; 97(1):105-9. PubMed ID: 16892790
    [Abstract] [Full Text] [Related]

  • 17. Approaches to the diagnosis and management of patients with a history of nonsteroidal anti-inflammatory drug-related urticaria and angioedema.
    Kowalski ML, Woessner K, Sanak M.
    J Allergy Clin Immunol; 2015 Aug; 136(2):245-51. PubMed ID: 26254051
    [Abstract] [Full Text] [Related]

  • 18. Immediate Reactions to More Than 1 NSAID Must Not Be Considered Cross-Hypersensitivity Unless Tolerance to ASA Is Verified.
    Pérez-Alzate D, Cornejo-García JA, Pérez-Sánchez N, Andreu I, García-Moral A, Agúndez JA, Bartra J, Doña I, Torres MJ, Blanca M, Blanca-López N, Canto G.
    J Investig Allergol Clin Immunol; 2017 Aug; 27(1):32-39. PubMed ID: 28211343
    [Abstract] [Full Text] [Related]

  • 19. Safety of selective COX-2 inhibitors in aspirin/nonsteroidal anti-inflammatory drug-intolerant patients: comparison of nimesulide, meloxicam, and rofecoxib.
    Bavbek S, Celik G, Ozer F, Mungan D, Misirligil Z.
    J Asthma; 2004 Feb; 41(1):67-75. PubMed ID: 15046380
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 32.